Covid19 relief program Ghana Cowtribe parasiticides Covid19 relief program Ghana Cowtribe parasiticides Boehringer Ingelheim and Cowtribe are kicking off a vital relief initiative in Ghana.
Drug Discovery at Boehringer Ingelheim Drug Discovery at Boehringer Ingelheim Find out more about the drug discovery process at Boehringer Ingelheim
2021 ABCD Young Scientist Award feline health 2021 ABCD Young Scientist Award feline health Young veterinary researchers Julia Klaus and Dr Yasmin Parr receive award for their work into feline SARS-CoV-2 infections and feline leukaemia virus.
Veterinary Product Adverse Events Veterinary Product Adverse Events Veterinary Product Adverse Events
On two wheels for more animal health On two wheels for more animal health Cowtribe’s social entrepreneurs win Boehringer Ingelheim's Accelerator Program.
Improving Access to Stroke Care Improving Access to Stroke Care Angels Initiative named Best Practice example by the Access to Medicine Index
Interview Dr Mehdi Shahidi Interview Dr Mehdi Shahidi Interview with Dr Mehdi Shahidi, Chief Medical Officer and Head of the Corporate Division Medicine at Boehringer Ingelheim
Winners of BVDzero Scholarship Programme Winners of BVDzero Scholarship Programme Boehringer Ingelheim announces winners of BVDzero Scholarship Programme
Big hearts united to help animals in Ukraine Big hearts united to help animals in Ukraine Veterinaries volunteer at the Polish-Ukrainian border to help welcome Refugees and their animals. Refugees don’t rest until their animals are safe.
Innovation in medicinal chemistry Innovation in medicinal chemistry Darryl McConnell, Research Site Head, Austria and Jürgen Mack, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
Cat care interview veterinarian Dr Susan Little Cat care interview veterinarian Dr Susan Little World-renowned feline healthcare specialist Dr. Susan Little shares her thoughts on latest trends in cat care.
Generalized pustular psoriasis at EADV 2021 Generalized pustular psoriasis at EADV 2021 Dr. Emmanuelle Clerisme-Beaty (former Associate Head of Medicine - Inflammation, Boehringer Ingelheim) reflects on developments for GPP at the EADV congress, 2021
Boehringer Ingelheim partners with GNA Biosolutions Boehringer Ingelheim partners with GNA Biosolutions Boehringer Ingelheim partners with GNA Biosolutions to develop African swine fever diagnostic test.
Veterinary oncology - cancer treatment Veterinary oncology - cancer treatment Our R&D team's efforts toward finding new cancer treatments for pets
Keep water clean Keep water clean Human beings can’t survive without water. Further, the safe production of medicines depends on clean drinking water.
Aservo EquiHaler wins Pharmapack Award 2021 Aservo EquiHaler wins Pharmapack Award 2021 Boehringer Ingelheim’s Aservo® EquiHaler® is recognized in the 2021 Pharmapack Awards
Mastitis dairy cows prevent antibiotic resistance Mastitis dairy cows prevent antibiotic resistance The Clinical and Laboratory Standards Institute (CLSI) approved revised interpretive criteria for the susceptibility testing of a mastitis product.
Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry Boehringer Ingelheim demonstrates its commitment to farm animal well-being by organising its 11th Expert Forum on Farm Animal Well-Being
NEJM-IL-36-Phase-1-GPP-data NEJM-IL-36-Phase-1-GPP-data Data published in The New England Journal of Medicine show rapid improvement of symptoms in patients with a rare form of pustular psoriasis
Tackling supply chain challenges for a country at war Tackling supply chain challenges for a country at war We are there for our patients – even in crisis regions. A supply chain success story with our Ukrainian colleague Tetiana Nagirna from Kyiv.
Diabetes dog symptoms chronic disease management Diabetes dog symptoms chronic disease management Learn about the symptoms of canine diabetes and how to manage the disease.
European Metacam® indication expanded to guinea pigs European Metacam® indication expanded to guinea pigs Boehringer Ingelheim adds a new species to its Metacam® brand in Europe, expanding the indications of this widely-used medicine to guinea pigs.
Patient Organizations Patient Organizations Boehringer Ingelheim’s core principles and vision guide our work with patient organisations.
Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD FDA Grants nintedanib Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype